AbbVie strikes tentative deal to settle 4,000-plus AndroGel lawsuits

AbbVie has had success defending against AndroGel lawsuits in court, but the drugmaker still faces thousands of lawsuits alleging harm from the testosterone drug. Now, the sides have reached a “potential global settlement,” according to a court filing Monday from Judge Matthew Kennelly.